Increased serum levels of ischemia-modified albumin and C-reactive protein in type 1 diabetes patients with ketoacidosis

Endocrine

Volumn 42, Issue 3, 2012, Pages 570-576

  Ma, Shao Gang ^a   Jin, Yue ^a   Xu, Wei ^a   Hu, Wen ^a   Bai, Feng ^a   Wu, Xiao Juan ^a  

^a THE AFFILIATED HUAIAN NO 1 PEOPLE S HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Biomarker; C reactive protein; Diabetic ketoacidosis; Ischemia modified albumin; Type 1 diabetes

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; INSULIN; ISCHEMIA MODIFIED ALBUMIN; BIOLOGICAL MARKER; GLYCOSYLATED HEMOGLOBIN; ISCHEMIA-MODIFIED ALBUMIN; LIPID; SERUM ALBUMIN;

ADULT; ALBUMIN BLOOD LEVEL; ANTHROPOMETRY; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DIABETIC KETOACIDOSIS; FEMALE; GLUCOSE BLOOD LEVEL; HOSPITAL ADMISSION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; BLOOD; BLOOD PRESSURE; BODY MASS; METABOLISM; MIDDLE AGED; PHYSIOLOGY; REGRESSION ANALYSIS;

ADULT; ANTHROPOMETRY; AREA UNDER CURVE; BIOLOGICAL MARKERS; BLOOD PRESSURE; BODY MASS INDEX; C-REACTIVE PROTEIN; DIABETES MELLITUS, TYPE 1; DIABETIC KETOACIDOSIS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LIPIDS; MALE; MIDDLE AGED; REGRESSION ANALYSIS; ROC CURVE; SERUM ALBUMIN;

EID: 84878245559     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-012-9652-9     Document Type: Article

References (30)

1. A. Gunduz, S. Turedi, A. Mentese, V. Altunayoglu, I. Turan, S.C. Karahan, M. Topbas, M. Aydin, I. Eraydin, B. Akcan, Ischemia-modified albumin levels in cerebrovascular accidents. Am. J. Emerg. Med. 26, 874-878 (2008)
2. S.G. Ma, W. Xu, C.L. Wei, X.J. Wu, B. Hong, Z.J. Wang, H.R. Hao, H.Q. Guo, Role of ischemia-modified albumin and total homocysteine in estimating symptomatic lacunar infarction in type 2 diabetic patients. Clin. Biochem. 44, 1299-1303 (2011)
3. S. Turedi, O. Cinar, I. Yavuz, A. Mentese, A. Gunduz, S.C. Karahan, M. Topbas, E. Cevik, A.O. Yildirim, A. Uzun, U. Kaldirim, Differences in ischemia-modified albumin levels between end stage renal disease patients and the normal population. J. Nephrol. 23, 335-340 (2010)
4. C.Y. Chen, W.L. Tsai, P.J. Lin, S.C. Shiesh, The value of serum ischemia-modified albumin for assessing liver function in patients with chronic liver disease. Clin. Chem. Lab. Med. 49, 1817-1821 (2011)
5. S.G. Ma, C.L. Wei, B. Hong, W.N. Yu, Ischemia-modified albumin in type 2 diabetic patients with and without peripheral arterial disease. Clinics (Sao Paulo). 66, 1677-1680 (2011)
6. Y. Iwasaki, Y. Hamamoto, Y. Kawasaki, H. Ikeda, S. Honjo, Y. Wada, H. Koshiyama, Japanese cases of acute onset diabetic ketosis without acidosis in the absence of glutamic acid decarboxylase autoantibody. Endocrine 37, 286-288 (2010)
7. J. Wolfsdorf, M.E. Craig, D. Daneman, D. Dunger, J. Edge, W.R. Lee, A. Rosenbloom, M.A. Sperling, R. Hanas, International society for pediatric and adolescent diabetes. Diabetic ketoacidosis. Pediatr. Diabetes. 8, 28-43 (2007)
8. R.R. Dalton, W.H. Hoffman, G.G. Passmore, S.L. Martin, Plasma C-reactive protein levels in severe diabetic ketoacidosis. Ann. Clin. Lab. Sci. 33, 435-442 (2003)
9. W.H. Hoffman, C.L. Burek, J.L. Waller, L.E. Fisher, M. Khichi, L.B. Mellick, Cytokine response to diabetic ketoacidosis and its treatment. Clin. Immunol. 108, 175-181 (2003)
10. C. Gabay, I. Kushner, Acute-phase proteins and other systemic responses to inflammation. N. Engl. J. Med. 340, 448-454 (1999)
11. K. Ukinc, S. Eminagaoglu, H.O. Ersoz, C. Erem, C. Karahan, A.B. Hacihasanoglu, M. Kocak, A novel indicator of widespread endothelial damage and ischemia in diabetic patients: ischemia-modified albumin. Endocrine 36, 425-432 (2009)
12. A. Piwowar, M. Knapik-Kordecka, M. Warwas, Comparison of the usefulness of plasma levels of oxidatively modified forms of albumin in estimating kidney dysfunction in diabetic patients. Clin. Invest. Med. 33, E109 (2010)
13. A. Turk, I. Nuhoglu, A. Mentese, S.C. Karahan, H. Erdol, C. Erem, The relationship between diabetic retinopathy and serum levels of ischemia-modified albumin and malondialdehyde. Retina 31, 602-608 (2011)
14. W. Wei, Q. Liu, Y. Tan, L. Liu, X. Li, L. Cai, Oxidative stress, diabetes, and diabetic complications. Hemoglobin 33, 370-377 (2009)
15. M.C. Vantyghem, M. Balduyck, F. Zerimech, A. Martin, C. Douillard, S. Bans, P.M. Degand, J. Lefebvre, Oxidative markers in diabetic ketoacidosis. J. Endocrinol. Invest. 23, 732-736 (2000)
16. F.B. Stentz, G.E. Umpierrez, R. Cuervo, A.E. Kitabchi, Proinflammatory cytokines, markers of cardiovascular risks, oxidative stress, and lipid peroxidation in patients with hyperglycemic crises. Diabetes 53, 2079-2086 (2004)
17. A. Piwowar, M. Knapik-Kordecka, M. Warwas, Ischemia-modified albumin level in type 2 diabetes mellitus - Preliminary report. Dis. Markers 24, 311-317 (2008)
18. A.B. Erbagci, M. Tarakcioglu, Y. Coskun, E. Sivasli, E. Sibel Namiduru, Mediators of inflammation in children with type I diabetes mellitus: cytokines in type I diabetic children. Clin. Biochem. 34, 645-650 (2001)
19. A. Viardot, S.T. Grey, F. Mackay, D. Chisholm, Potential antiinflammatory role of insulin via the preferential polarization of effector T cells toward a T helper 2 phenotype. Endocrinology 148, 346-353 (2007)
20. M. Firoozrai, M. Nourbakhsh, M. Razzaghy-Azar, Erythrocyte susceptibility to oxidative stress and antioxidant status in patients with type 1 diabetes. Diabetes Res. Clin. Pract. 77, 427-432 (2007)
21. M. Krzystek-Korpacka, B. Salmonowicz, D. Boehm, I. Berdowska, B. Zielinski, E. Patryn, A. Noczynska, A. Gamian, Diagnostic potential of oxidative stress markers in children and adolescents with type 1 diabetes. Clin. Biochem. 41, 48-55 (2008)
22. Z. Rasheed, H.A. Al-Shobaili, A.A. Alzolibani, M. Ismail Khan, M. Tariq Ayub, M.I. Khan et al., Immunological functions of oxidized human immunoglobulin G in type 1 diabetes mellitus: its potential role in diabetic smokers as a biomarker of elevated oxidative stress. Dis. Markers 31, 47-54 (2011)
23. A. Ceriello, K. Esposito, M. Ihnat, J. Thorpe, D. Giugliano, Effect of acute hyperglycaemia, long-term glycaemic control and insulin on endothelial dysfunction and inflammation in Type 1 diabetic patients with different characteristics. Diabet. Med. 27, 911-917 (2010)
24. A.E. Kitabchi, F.B. Stentz, G.E. Umpierrez, Diabetic ketoacidosis induces in vivo activation of human T-lymphocytes. Biochem. Biophys. Res. Commun. 315, 404-407 (2004)
25. N.S. Glaser, S.L. Wootton-Gorges, M.H. Buonocore, J.P. Marcin, A. Rewers, J. Strain, J. DiCarlo, E.K. Neely, P. Barnes, N. Kuppermann, Frequency of sub-clinical cerebral edema in children with diabetic ketoacidosis. Pediatr. Diabetes 7, 75-80 (2006)
26. R. Hanas, F. Lindgren, B. Lindblad, Diabetic ketoacidosis and cerebral oedema in Sweden-a 2-year paediatric population study. Diabet. Med. 24, 1080-1085 (2007)
27. A.L. Rosenbloom, The management of diabetic ketoacidosis in children. Diabetes Ther. 1, 103-120 (2010)
28. X. Zhang, C. Chen, A new insight of mechanisms, diagnosis and treatment of diabetic cardiomyopathy. Endocrine. 2012 Feb 10. [Epub ahead of print]
29. L. Weiss, S. Bernstein, R. Jones, R. Amunugama, D. Krizman, L. Jebailey, O. Almogi-Hazan, Z. Yekhtin, R. Shiner, I. Reibstein, E. Triche, S. Slavin, R. Or, E.R. Barnea, Preimplantation factor (PIF) analog prevents type I diabetes mellitus (TIDM) development by preserving pancreatic function in NOD mice. Endocrine 40, 41-54 (2011)
30. S. Sivanandan, A. Sinha, V. Jain, R. Lodha, Management of diabetic ketoacidosis. Indian J. Pediatr. 78, 576-584 (2011)